» Articles » PMID: 17278188

Clinical Role and Importance of Fluorescence in Situ Hybridization Method in Diagnosis of H Pylori Infection and Determination of Clarithromycin Resistance in H Pylori Eradication Therapy

Overview
Specialty Gastroenterology
Date 2007 Feb 6
PMID 17278188
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

H pylori is etiologically associated with gastritis, gastric and duodenal ulcers, gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Eradicating H pylori may convert rapidly the outcome of related diseases with the use of more accurate diagnostic molecular tests. Indeed some of the tests cannot give the evidence of current infection; H pylori can be detected by noninvasive and invasive methods, the latter requiring an endoscopy. Eradication failure is a big problem in H pylori infection. Recently, clarithromycin resistance in H pylori strains is increasing and eradication therapy of this bacterium is becoming more difficult. Molecular methods have frequently been applied besides phenotypic methods for susceptibility testing to detect clarithromycin resistance due to mutations in the 2143 and 2144 positions of 23S rRNA gene. Fluorescence in situ hybridization (FISH) method on paraffin embedded tissue is a rapid, accurate and cost-effective method for the detection of H pylori infection and to determine clarithromycin resistance within three hours according to the gold standards as a non-culture method. This method can also be applied to fresh biopsy samples and the isolated colonies from a culture of H pylori, detecting both the culturable bacillary forms and the coccoid forms of H pylori, besides the paraffin embedded tissue sections. This technique is helpful for determining the bacterial density and the results of treatment where clarithromycin has been widely used in populations to increase the efficacy of the treatment and to clarify the treatment failure in vitro.

Citing Articles

Optimizing Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments.

Ishibashi F, Suzuki S, Nagai M, Mochida K, Morishita T Gut Liver. 2023; 17(5):684-697.

PMID: 36843419 PMC: 10502504. DOI: 10.5009/gnl220429.


Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Tshibangu-Kabamba E, Yamaoka Y Nat Rev Gastroenterol Hepatol. 2021; 18(9):613-629.

PMID: 34002081 DOI: 10.1038/s41575-021-00449-x.


Sequencing-based methods and resources to study antimicrobial resistance.

Boolchandani M, DSouza A, Dantas G Nat Rev Genet. 2019; 20(6):356-370.

PMID: 30886350 PMC: 6525649. DOI: 10.1038/s41576-019-0108-4.


Peptide Nucleic Acid Probe-Based Analysis as a New Detection Method for Clarithromycin Resistance in .

Jung D, Kim J, Jeong S, Park S, Kang I, Lee K Gut Liver. 2018; 12(6):641-647.

PMID: 30037168 PMC: 6254629. DOI: 10.5009/gnl18111.


Rapid identification of and assessment of clarithromycin susceptibility from clinical specimens using FISH.

Demiray-Gurbuz E, Yilmaz O, Olivares A, Gonen C, Sarioglu S, Soyturk M J Pathol Clin Res. 2017; 3(1):29-37.

PMID: 28138399 PMC: 5259560. DOI: 10.1002/cjp2.57.


References
1.
Vinette K, Gibney K, Proujansky R, Fawcett P . Comparison of PCR and clinical laboratory tests for diagnosing H. pylori infection in pediatric patients. BMC Microbiol. 2004; 4:5. PMC: 338288. DOI: 10.1186/1471-2180-4-5. View

2.
Megraud F . Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther. 1997; 11 Suppl 1:43-53. DOI: 10.1046/j.1365-2036.11.s1.11.x. View

3.
Park C, Kim J . Rapid and easy detection of Helicobacter pylori by in situ hybridization. J Korean Med Sci. 1999; 14(1):15-20. PMC: 3054156. DOI: 10.3346/jkms.1999.14.1.15. View

4.
Versalovic J, Shortridge D, Kibler K, Griffy M, Beyer J, Flamm R . Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1996; 40(2):477-80. PMC: 163139. DOI: 10.1128/AAC.40.2.477. View

5.
Morris J, Reasonover A, Bruce M, Bruden D, McMahon B, Sacco F . Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol. 2005; 43(7):3494-6. PMC: 1169084. DOI: 10.1128/JCM.43.7.3494-3496.2005. View